For patients from Saudi Arabia

Stem cell therapy for Back & Disc Degeneration — for patients from Saudi Arabia

A Back & Disc Degeneration programme at Stem Plus in Sofia is €3,000–€8,000, versus roughly €20,000–€40,000 in Saudi Arabia. About 5.2h from Riyadh, inside the EU, visa-free.

If you are researching Back & Disc Degeneration treatment from Saudi Arabia, the obstacle is usually access or cost: standard options have plateaued, and regenerative therapy at home runs to €20,000–€40,000. Stem Plus offers the same European GMP standard for a fraction of that — and an easy, mostly visa-free trip.

Back & Disc Degeneration treatment cost — Saudi Arabia vs Bulgaria
Bulgaria (Stem Plus)€5,500
Saudi Arabia€30,000

How Back & Disc Degeneration is treated

Targeted MSC protocols aim to calm inflammation in degenerative discs and facet joints, addressing chronic mechanical back pain without spinal fusion. It is delivered under a physician-led protocol and designed to complement your existing care.

Evidence: Reported reductions in disc-related pain in selected patients. (clinical studies). Offered as an individualised programme, not a guaranteed cure.

Your cost from Saudi Arabia

Saudi Arabia (home)Stem Plus · EU
Back & Disc Degeneration treatment€20,000–€40,000€3,000–€8,000
RegulationvariesEU · GMP
Flight to Sofia5.2h from Riyadh

Safety & practicalities note

EUBulgaria is a full European Union member — EU consumer, data and medical-oversight frameworks apply.
Low crime and a long-standing, safe medical-tourism record; English-speaking patient team.
Visa-free for US, UK, Canada, Gulf (GCC) and EU visitors for short medical stays (typically 90 days).
Euro-area pricing transparency: a fixed written quote before you travel — no open-ended bills.

This note is general information for planning, not legal or medical advice. Confirm entry rules for your nationality before booking.

Cost ranges are indicative market figures for planning, not quotes.

Terapia celular de nivel europeo, sin precios europeos.

Medicina regenerativa certificada GMP en el corazón de la UE — desde 3.000–8.000 €, una fracción de los precios de EE. UU. o Alemania. Protocolos personalizados para pacientes de más de 50 países.

Evaluación médica gratuita